Anthocyanins: targeting of signaling networks in cancer cells

Area of Science:

• Phytochemistry
• Cancer Biology
• Nutrigenomics

Background:

• Phytochemicals from edible plants are increasingly recognized for their therapeutic potential.
• In-vitro and in-vivo studies demonstrate anthocyanins possess anticancer properties.
• Bilberry anthocyanins are being explored for chemoprevention in colorectal cancer patients.

Purpose of the Study:

• To review the mechanisms by which anthocyanins induce apoptosis in cancer cells.
• To highlight the role of anthocyanins in cancer treatment and prevention.
• To discuss the implications of nutrigenomics in understanding anthocyanin action.

Main Methods:

• Review of existing in-vitro and in-vivo studies on anthocyanins and cancer.
• Analysis of clinical evaluations of bilberry anthocyanins in cancer patients.
• Examination of research on nutrigenomics and anthocyanin-mediated signaling pathways.

Main Results:

• Anthocyanin treatment leads to the up-regulation of tumor suppressor genes in cancer cells.
• Anthocyanins activate both extrinsic and intrinsic apoptotic pathways.
• Evidence suggests common molecular targets for anthocyanins within intracellular signaling cascades.

Conclusions:

• Anthocyanins demonstrate significant potential as anticancer agents.
• Translational research is bridging laboratory findings to clinical applications.
• Further investigation into anthocyanins' role in cancer prevention and therapy is warranted.